Aromatase and COX-2 expression in human breast cancers
- 1 December 2001
- journal article
- Published by Elsevier in The Journal of Steroid Biochemistry and Molecular Biology
- Vol. 79 (1-5), 41-47
- https://doi.org/10.1016/s0960-0760(01)00131-5
Abstract
No abstract availableKeywords
This publication has 25 references indexed in Scilit:
- Comprehensive Pharmacology and Clinical Efficacy of Aromatase InhibitorsDrugs, 1999
- Concentration of Sex Steroids in Adipose Tissue after MenopauseSteroids, 1998
- Estrogen biosynthesis proximal to a breast tumor is stimulated by PGE2 via cyclic AMP, leading to activation of promoter II of the CYP19 (aromatase) geneEndocrinology, 1996
- Expression of aromatase protein and messenger ribonucleic acid in tumor epithelial cells and evidence of functional significance of locally produced estrogen in human breast cancersEndocrinology, 1996
- Prognostic value of breast cancer aromataseCancer, 1992
- Relationship between tumour aromatase activity, tumour characteristics and response to therapyThe Journal of Steroid Biochemistry and Molecular Biology, 1990
- in situ oestrone synthesis in normal breast and breast tumour tissues: Effect of treatment with 4‐hydroxyandrostenedioneInternational Journal of Cancer, 1989
- A comparison of thein vivo uptake and metabolism of3H-oestrone and3H-oestradiol by normal breast and breast tumour tissues in post-menopausal womenInternational Journal of Cancer, 1986
- Aromatase, 17β-hydroxysteroid dehydrogenase and intratissular sex hormone concentrations in cancerous and normal glandular breast tissue in postmenopausal womenEuropean Journal of Cancer and Clinical Oncology, 1986
- The Effect of an Aromatase Inhibitor, 4-Hydroxy-4-Androstene- 3,17-Dione, On Estrogen-Dependent Processes in Reproduction and Breast Cancer11Endocrinology, 1977